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Abstract
Partial bladder outlet obstruction (PBOO), a common urologic pathology mostly caused by benign prostatic hyperplasia, can
coexist in 40–45% of patients with overactive bladder (OAB) and is associated with detrusor overactivity (DO). PBOO that
induces DO results in alteration in bladder myosin II type and isoform composition. Blebbistatin (BLEB) is a myosin II
inhibitor we recently demonstrated potently relaxed normal detrusor smooth muscle (SM) and reports suggest varied BLEB
efficacy for different SM myosin (SMM) isoforms and/or SMM vs nonmuscle myosin (NMM). We hypothesize BLEB inhibition
of myosin II as a novel contraction protein targeted strategy to regulate DO. Using a surgically-induced male rat PBOO
model, organ bath contractility, competitive and Real-Time-RT-PCR were performed. It was found that obstructed-bladder
weight significantly increased 2.74-fold while in vitro contractility of detrusor to various stimuli was impaired ,50% along
with decreased shortening velocity. Obstruction also altered detrusor spontaneous activities with significantly increased
amplitude but depressed frequency. PBOO switched bladder from a phasic-type to a more tonic-type SM. Expression of 5’
myosin heavy chain (MHC) alternatively spliced isoform SM-A (associated with tonic-type SM) increased 3-fold while 3’ MHC
SM1 and essential light chain isoform MLC17b also exhibited increased relative expression. Total SMMHC expression was
decreased by 25% while the expression of NMM IIB (SMemb) was greatly increased by 4.5-fold. BLEB was found to
completely relax detrusor strips from both sham-operated and PBOO rats pre-contracted with KCl, carbachol or electrical
field stimulation although sensitivity was slightly decreased (20%) only at lower doses for PBOO. Thus we provide the first
thorough characterization of the response of rat bladder myosin to PBOO and demonstrate complete BLEB-induced PBOO
bladder SM relaxation. Furthermore, the present study provides valuable evidence that BLEB may be a novel type of
potential therapeutic agent for regulation of myogenic and nerve-evoked DO in OAB.
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Introduction
Smooth muscle (SM) myosin (SMM) is the thick filament and
motor molecule of the SM contractile apparatus, composed of a pair
of myosin heavy chains (MHCs) and two pairs of myosin light chains
(MLC17 and MLC20) that are intimately intertwined [1]. It has been
shown that both the 39 and 59 end of the MHC pre-mRNA are
alternatively spliced to generate COOH-terminal (SM1 and SM2)
and NH2-terminal (SM-A and SM-B) isoforms, respectively. The
SM-B isoform is predominantly found in SMs that demonstrate a
more phasic contractile nature, faster shortening velocity and higher
ATPaseactivity (e.g., urinary bladder,saphenous artery),whereas the
SM-A isoform is found in slower more tonic-type SM with lower
ATPase activity (e.g., aorta) [2–5]. Also, the essential light chain
MLC17 is alternatively spliced and has two 3’ isoforms known as
MLC17a and MLC17b [6,7].SimilartotheSM-AandSM-Bisoforms,
the relative ratio of the MLC17 isoforms has been associated with the
tonicity of SM with a higher ratio of MLC17a to MLC17b being
associated with a more phasic type contraction [2,8,9].
Blebbistatin (BLEB) is a small cell permeable selective myosin II
inhibitor that was originally discovered as the result of a high
throughput screen for inhibitors of nonmuscle myosin (NMM) II
[10]. Although originally thought to be much less efficacious on
SM than NMMII, BLEB has now been suggested to inhibit SM
contraction with near equipotency [11–13].
However, some data have suggested that BLEB is more
efficacious at inhibiting SM tissues that express more SM-B
SMM isoform. For example, Rhee et al. showed that force
maintenance was inhibited by BLEB to a greater percent in
bladder (mainly SM-B) than in aorta (mainly SM-A) while
maximum bladder SM contraction was not altered but aortic
SM was actually increased in the presence of BLEB [14]. In
contrast, KCl-induced contraction of chicken gizzard (almost
completely SM-B) was less potently (IC50 ,20 mM) inhibited than
the carotid artery that expresses predominantly SM-A (IC50
,3 mM) [11]. Thus, the influence of SM-A/SM-B splicing, which
occurs very close to the BLEB binding site on the head of the
myosin molecule and near the ATP cleavage site, is controversial.
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e25958In addition, it has been suggested that NMM II may contribute
to tonic force maintenance [15–18]. Ekman et al. showed that
BLEB was much more effective at inhibiting SM from neonatal vs
adult bladder SM which expresses much lower levels of NMM II
[16]. However, in contrast, Eddinger et al. showed that rabbit
arterial SM was potently inhibited by BLEB (IC50 ,5 mM)
although this tissue does not express significant amounts of NMM
II [11]. Thus, clearly the effect of SMM composition and relative
amount of NMM II on BLEB efficacy also remains to be
elucidated.
Most recently we provided novel data that BLEB also potently
relaxed both rat and human bladder SM in vitro and rat detrusor in
vivo and it was suggested that BLEB could be developed as a
potential agent for overactive bladder (OAB) [13]. Partial bladder
outlet obstruction (PBOO), a common urologic pathology mostly
caused by benign prostatic hyperplasia (BPH), occurs in up to 70%
of men over 60 years old [19]. However, OAB can coexist in 40–
45% of patients with PBOO [20] and is associated with detrusor
overactivity (DO) [21]. It has been documented that PBOO is
associated with overexpression of SM-A and other SMM isoforms
in obstructed animals with alteration in the expression of NMM II
as well [22]. Concomitantly, the contractile characteristics of the
bladder alter from a phasic to a more tonic-type contraction
[22–26]. Thus, the aim of the current study was to investigate the
effect of PBOO on rat bladder SMM isoform composition, NMM
IIB expression and functional activities and to determine whether
the effectivenessof BLEBis altered in the detrusor from PBOO rats.
Materials and Methods
Chemicals and tissues
All chemicals were from Sigma (St. Louis, USA) except (6)
BLEB was from Tocris (Ellisville, MO, USA). The racemic
mixture (6) of BLEB was used in all studies as it was determined
that the active (-) enantiomer form was equipotent to the (6)
racemic mixture in the in vitro studies and that the inactive (+) form
did not induce significant relaxation [10,11,13,27]. A stock
solution of BLEB was made in dimethylsulphoxide (DMSO); the
other substances were dissolved daily in double distilled water.
Control experiments showed that the final concentrations (1/
1000–3/1000) of DMSO used in these studies did not significantly
modify the relaxation response induced by (6) BLEB. Due to the
known light sensitivity of BLEB, it was always kept in the dark in
the refrigerator until just prior to usage and during the experiment,
the organ bath chambers were kept covered. Male rat urinary
bladders were obtained from adult male Sprague-Dawley (SD) rats
(Charles River; Raleigh, NC, USA). All animal studies were
approved by the Animal Institute Committee of the Albert
Einstein College of Medicine (study approval number 20100201).
Partial bladder outlet obstruction model
As previously reported [28,29], rats were anesthetized with
pentobarbital (35 mg/kg) via an intraperitoneal (i.p) injection. A
2 cm midline vertical incision was made from the penoscrotal
junction to the midscrotum to gain access to the bulbous urethra.
The urethra was then isolated from the cavernous bodies. A sterile
metal bar (19 gauge needle) with a 1.06 mm diameter was placed
on the bulbous urethral surface, and a 3-0 polypropylene suture
was used to place a tie around both the bulbous urethra and the
bar. As soon as the suture was secured, the bar was removed,
leaving the bulbous urethra partially obstructed. A 4-0 silk suture
was used to reapproximate the muscle layer, and a 4-0 nylon
suture was used to close the skin. Sham surgery was performed the
same as described above except the urethral ties were not placed.
All animals were kept 2 weeks on normal chow with a 12 h day/
night light cycle.
In vitro organ bath studies
The in vitro contractility studies were performed as previously
described [12,13,30,31]. Briefly, bladder dome strips containing
urothelium with identical length were mounted longitudinally in a
4 ml Multi-Myograph Model 810MS (Danish Myo Technology;
Aarhus, Denmark) organ bath. The myograph was connected in
line to a PowerLab 4/30 Data Acquisition System (ADInstru-
ments; Colorado Springs, CO, USA) and in turn to a Dual-Core
processor Pentium computer for real-time monitoring of physio-
logical force. The SM strips were equilibrated at least 1 h in
Krebs-Henseleit (Krebs) buffer [12,13,28,30,31] at 37uC with
continuous bubbling of 95% O2 and 5% CO2. The buffer had the
Table 1. Primer sequences used to amplify target genes by
PCR.














Table 2. Rat body weight and bladder weight.
Group Body wt (g) Bladder wt (g) %Bladder wt/Body wt
Initial Final
Control (n =14) 379.2617.3 462.5613.0 145.069.6 0.03260.002




**=P ,0.001 vs control.
doi:10.1371/journal.pone.0025958.t002
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MgSO4 1.2, KH2PO4 1.2, NaHCO3 25 and dextrose 11 and it
was changed every 15 minutes (min). Strips were continuously
adjusted to 500–700 mg resting tension [32,33]. After equilibra-
tion, rat detrusor was contracted with 60 mM KCl, cumulative
concentrations (10
28–10
24 M) of carbachol or electrical field
stimulation (EFS) at varying frequencies of 2, 4, 8, 16 and 32 Hz,
duration 1.5 ms, train 5 s, and 80 V. Force produced by the above
stimuli was normalized to strip weight. Next, strips were pre-
contracted with 3 mM carbachol and allowed to reach stable
tension and then the relaxant effects of increasing doses of BLEB
were evaluated. Additionally, after pre-incubation with (6)BLEB
(20 mM, equal to 10 mM active BLEB) for 30 min, its inhibitory
effect on carbachol (3 mM) or aforementioned EFS mediated
contractility was also tested.
RNA extraction and cDNA synthesis
Total RNA was extracted using TRIzol reagent (Invitrogen;
Carlsbad, CA, USA) according to the manufacturer’s protocol.
Briefly, the tissue was ground into a powder using a mortar and
pestle cooled in liquid nitrogen without allowing the tissue to thaw.
The powder then was homogenized immediately in denaturing
buffer using a T8 Ultra-Turrax minielectric homogenizer (IKA
Works; Wilmington, NC, USA), chloroform was added and
mixed, the phases separated by centrifugation, and the RNA
precipitated by isopropanol and then washed with 70% ethanol
and dissolved in RNase-free sterile water. The resulting RNA was
quantitated by spectrophotometry at 260/280 nm. Total RNA
Figure 1. Typical tracings of rat urinary bladder strip spontaneous contractions. Stable spontaneous activity of rat detrusor strips was
recorded. The x-axis represents time (min) while the y-axis represents force (mg). Upper panel is from the sham group while the lower panel is from
the PBOO group.
doi:10.1371/journal.pone.0025958.g001
Table 3. Spontaneous activities of rat detrusor strips.
Group Frequency (cycles/10 min) Amplitude (mg)
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PLoS ONE | www.plosone.org 3 October 2011 | Volume 6 | Issue 10 | e25958Figure 2. Rat bladder smooth muscle in vitro contractility in response to KCl. Left (sham) and middle (PBOO) panels are typical tracings. The
x-axis represents time (s) while the y-axis represents force (mg). Accordingly, right panel is summary graph for the representative data shown in left
and middle panels. Responses were normalized to strip weight. Values are expressed as mean 6 SEM. **=p,0.01 vs PBOO. (n =strips obtained from
25 different animals, one to two strips were used for each animal).
doi:10.1371/journal.pone.0025958.g002
Figure 3. Rat bladder smooth muscle in vitro contractility in response to carbachol. Left panels are typical tracings. Upper portion of left
panel is sham group while lower portion is PBOO group. The x-axis represents time (s) while the y-axis represents force (mg). Accordingly, right panel
is summary graph for the representative data shown in left panels. Responses were normalized to strip weight. Values are expressed as mean 6 SEM.
(n= strips obtained from 25 different animals, one to two strips were used for each animal).
doi:10.1371/journal.pone.0025958.g003
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primer (Invitrogen), 500 mM dNTPs (Invitrogen), and 200 U of
SuperScript II RNase H reverse transcriptase in a total volume of
20 ml for 50 min at 42uC.
Competitive reverse transcriptase polymerase chain
reaction (competitive RT-PCR)
As previously reported [34], polymerase chain reaction (PCR)
was performed on 100 ng of the reverse transcribed cDNA using 2
units of Red Taq DNA polymerase (Sigma; St Louis, MO, USA),
200 ng each of upstream and downstream primer and 200 mM
dNTPs (Invitrogen). SM-A/SM-B, SM1/SM2 and MLC17a/
MLC17b isoforms were amplified with competitive PCR, using a
GeneAmp 9700 thermal cycler (Applied Biosystems; Foster City,
CA, USA). The primer sequences are shown in Table 1. The
cycling conditions were an initial 5 min at 94uC followed by 35
cycles (30 s at 94uC, 30 s at 55uC, and 120 s at 72uC), followed by
a final one-time 7 min incubation at 72uC to ensure extension of
all products.
The PCR products were then separated by electrophoresis on a
2.5% agarose gel and were visualized using GelStar (Cambrex Bio
Science Rockland, Inc.; Rockland, ME, USA) staining and
ultraviolet illumination. Band density was quantified by reflectance
scanning of gel photographs obtained with a BioDoc-It camera
setup (UVP; Upland, CA, USA) using a Bio-Rad (Hercules, CA,
USA) GS-700 imaging densitometer and subsequent analyses
using the Bio-Rad Molecular Analyst 1D program that enabled us
to obtain quantitative relative SMM isoform transcript expression
data for all isoform pairs.
Real-Time reverse transcriptase polymerase chain
reaction (Real-Time RT-PCR)
As previously reported [31], RT products were also amplified in
a 96-well plate in a 25 ml reaction volume with all samples run in
triplicate, using the model 7300 Real-Time Thermocycler
(Applied Biosystems). The following experimental protocol was
utilized: denaturation (95uC for 10 min to activate the polymerase)
followed by an amplification program repeated for 40 cycles (95uC
for 15 s, then 60uC for 60 s) using a single fluorescence
measurement. SMMHC and NMMHC targeted genes were
amplified using SYBR Green for amplicon detection. For relative
quantification, the efficiency of amplification for each individual
primer pair (sequences shown in Table 1) was determined using
Figure 4. Rat bladder smooth muscle in vitro contractility in response to EFS. Upper panels are typical tracings. Left portion of upper panel
is sham group while right portion is PBOO group. Accordingly, lower panel is summary graph for the representative data shown in left panels.
Responses were normalized to strip weight. Values are expressed as mean 6 SEM. **=p,0.01 vs PBOO. (n =strips obtained from 25 different
animals, one to two strips were used for each animal).
doi:10.1371/journal.pone.0025958.g004
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-DDct method [35] in conjunction with the
RQ Study Software version 1.2.3 (Applied Biosystems). Gene
expression was normalized to expression of the RPL19 ribosomal
housekeeping gene.
Statistical analysis
Results are expressed as mean 6 SEM for n experiments.
Statistical analysis was performed using either the Student’s t-test
(when two sample treatments were being compared) or using
ANOVA when multiple means were compared. p,0.05 was
considered significant.
Results
Enlarged bladder mass was observed in the PBOO group with
mean bladder weight significantly increased from 145.069.6 mg
to 398.0636.9 mg (P,0.001) representing a 2.74-fold increase.
Since the body weight actually decreased in the PBOO rats, the
bladder-to-body weight ratio actually increased 3.25-fold (Table 2).
Almost all bladder SM strips, after 30 min of equilibration at a
resting tension of 500–700 mg displayed spontaneous contractions
(Fig. 1). Obstruction altered detrusor spontaneous activities with
contraction amplitude significantly increased (from 626 to
1191 mg force) but frequency significantly decreased (from 42.3
to 16.1 cycles/10 min) on average (Fig. 1, Table 3). PBOO also
lessened bladder SM in vitro contractility and heightened tonicity.
The force produced by bladder strips from PBOO rats was
lowered by ,50% in response to KCl depolarization (Fig. 2). For
muscarinic receptor activation, ,35% less contraction was
observed at higher doses (10
25 and 10
24 M) of carbachol
stimulation but there were no significant differences at lower
concentrations (10
28 to 10
26) while EC50s were similar at 2.09 and
1.19 mM for sham and PBOO, respectively (Fig. 3). PBOO was
also associated with a 55–60% decrease in force generation in
response to EFS at all stimulation frequencies (Fig. 4).
PBOO bladder SM also exhibited a decreased shortening
velocity as reflected by an approximately 2.5-fold slower time to
50% maximum contraction in response to both KCl and
carbachol mediated contraction (27.968.3 vs 10.262.1 S and
35.068.0 vs 15.462.0 S, respectively)(Figs. 2 & 3) and much better
maintenance of force. Consistent with elevated tonicity, obstruc-
tion altered bladder SMM isoform composition with the
expression of SM-A relative to SM-B increased approximately 3-
fold (from ,10% to 30%) while MLC17b (from 30% to 35%) and
Figure 5. Rat detrusor smooth muscle myosin isoform composition. Panels A-C are representative GelStar-stained agarose gels of cDNA
products resulting from competitive RT-PCR analysis of the SMMHC pre-mRNA of the 5’ region containing the SM-A/SM-B alternative splice site, the
17 kDa essential MLC pre-mRNA of the 3’ region containing the MLC17a/MLC17b alternative splice site and the SMMHC pre-mRNA 3’ region containing
the SM1/SM2 alternative splice site from sham and PBOO rats, respectively. Panel D shows averaged quantitative determination of SMM pre-mRNA
mean isoform percentages in detrusor determined by using the information gathered from gels as in panels A–C. Values are expressed as mean 6
SEM. *=p,0.05 vs PBOO; **=p,0.01 vs PBOO. (n =5 different animals for each group).
doi:10.1371/journal.pone.0025958.g005
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extent (Fig. 5).
To determine whether the altered SMM isoform composition in
the PBOO rat bladder influences BLEB inhibitory ability, various
physiological experiments were performed. The results shown in
Figs. 6 & 9 reveal that BLEB strongly and dose-dependently
relaxed carbachol pre-contracted bladder SM strips from both
sham and PBOO rats but exhibited ,15% less efficacy in relaxing
detrusor strips from PBOO rats at the lower doses of 1 mM and
5 mM but no difference was noted at 15 mM, a dose which totally
attenuated the contraction of both preparations.
Preincubation of detrusor strips with 20 mM( 6) BLEB (equal to
10 mM active BLEB) effectively inhibited 3 mM carbachol-induced
tension increase for both sham and PBOO rats but inhibition was
,20% less on detrusor from PBOO rats (Figs. 7 & 9). BLEB
substantially inhibited EFS-induced contraction at all stimulation
frequencies with inhibition at 2 Hz being more pronounced.
When compared with sham, similarly, an approximately 20%
lesser inhibition rate was observed frequency by frequency in
PBOO rats (Figs. 8 & 9).
Finally, as some have suggested BLEB to be more efficacious on
NMM II than SMM as described in the Introduction, we
performed Real-Time PCR to quantify the relative expression of
SMM II and NMM II. As demonstrated in Fig. 10, MHC
transcript expression was significantly downregulated by approx-
imately 30% while NMM expression was strongly upregulated
,4.5- fold in obstructed bladder resulting in a more than 5-fold
increase in the relative ratio of NMMHC II to SMMHC II
transcripts.
Discussion
The present study demonstrated that 2-week PBOO induced a
significant relative overexpression of the SM-A and SM1
SMMHC isoforms as well as the MLC17b essential light chain
isoform in the rat bladder, which was associated with a switch to a
more tonic-type SM contraction phenotype. Our novel data also
revealed that the Type II myosin selective inhibitor BLEB potently
relaxed detrusor SM, with sensitivity only slightly attenuated for
detrusor from rats with PBOO but BLEB still able to provoke
complete relaxation.
Our PBOO rat model was validated by a ,3.5-fold increase in
bladder weight within the 2-week obstruction period. It has been
shown that PBOO can result in either a mild or severe obstruction
Figure 6. Representative tracings of BLEB-induced relaxation effects on detrusor SM pre-contracted with carbachol. Upper portion is
the sham group while the lower portion is the PBOO group. The x-axis represents time (min) while the y-axis represents force (mg).
doi:10.1371/journal.pone.0025958.g006
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and the diameter of the surgical ligation [37]. In our study, we
placed a 1.06 mm outer diameter 19 gauge needle on the bulbous
urethral surface and tied the suture around the urethra with the
needle bar similar to the technique used by Saito et al. to induce
severe obstruction [37]. In the Saito et al. study, a ligation around
a 1.09 mm catheter produced a 4-fold bladder weight increase
close to our 3.5-fold increase, while an obstruction classified as
mild was induced using a 1.70 mm outer diameter catheter and
resulted in an average of only an approximately 80% increase in
bladder weight.
Isolated detrusor strips of many small animals, including rats,
often develop spontaneous activity, generally occurring upon
action potential discharge resulting in Ca
2+ influx through L-type
Ca
2+ channels and associated Ca
2+ transients [38]. Our current
data revealed that frequencies of spontaneous contractions in
detrusors from sham rats outnumbered the ones from PBOO rats
which became less phasic as stated above (Fig. 1 & Table 3).
However, our data demonstrated that PBOO significantly
heightened the amplitude of spontaneous contraction when
compared to sham (Fig. 1 & Table 3). Yet, the exact mechanism
underlying these pathophysiological changes remains to be
ascertained.
As previously reported in male PBOO animals with more severe
obstruction, bladder SM contractility was found altered in the
present study with not only a switch to a more tonic-type
contraction [22,39,40] but also a decrease in maximum force
generation (35–50%) [25,40–42] in response to various stimuli,
including KCl depolarization, carbachol muscarinic receptor
activation and EFS frequency-dependent intramural nerve
activation (Figs. 2–4). Of note, at lower concentrations (10
28–
10
26 M) of carbachol stimulation, contractile performance did not
differ between the sham and PBOO group (Fig. 3), which may be
attributed to increased sensitivity and an upregulation of M2
receptor expression in obstructed bladders to accommodate force
loss as shown by other labs [43,44].
It is likely that the loss of contractility may be associated with
significant intracellular and extracellular changes: dysregulation of
SM contractile protein expression, impaired energy production
(mitochondrial dysfunction), calcium signaling abnormality, and
increased detrusor collagen and relative denervation [45,46].
However, SMM myosin isoform composition, the topic of our
Figure 7. Representative tracings of BLEB-induced inhibitory effects on carbachol induced detrusor SM contractions. Upper portion
is the sham group while the lower portion is the PBOO group. The x-axis represents time (min) while the y-axis represents force (mg).
doi:10.1371/journal.pone.0025958.g007
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either SM-B [47] or SM2 [48] has been demonstrated to greatly
alter bladder SM contractility. In fact, in the current study,
obstruction for 2 weeks significantly increased the mRNA level of
SM-A 3-fold from 10% to 30% (Figs. 5A & D), paralleling the
aforementioned more tonic-type bladder SM contraction and
previous studies in other species [22,25]. Also our approximate
50% decreased contraction in the PBOO rat bladder correlates
well with the lessened isometric detrusor force generation by
almost 50% in the SM-B isoform knockout mice [47]. Moreover,
to our knowledge, our current study is the first report on the effect
of PBOO on the relative expression of the SM-A and SM-B
alternatively spliced SMM isoform pair in the rat.
In addition to the attenuated contraction, the time to reach 50%
maximal contraction was increased by PBOO for both KCl and
carbachol stimulation at 27.968.3 vs 10.262.1 S and 35.068.0 vs
15.462.0 S, respectively, as can be seen in Figs. 2 & 3. The
deceased shortening velocity of the detrusor from PBOO rats
correlated with the slower shortening velocity measured in aorta
(expressing mainly SM-A) compared to saphenous artery (express-
ing mainly SM-B) [5] and the decreased shortening velocity of
bladder SM from SM-B knockout compared to wild type mice
[47,49]. Hence, the switch to a greater SM-A isoform composition
for PBOO bladder is related to a decreased force generation and
shortening velocity resembling a more tonic SM phenotype.
We further characterized the 3’ alternatively spliced SM1/SM2
and the essential light chain isoforms. The relative expression of
the MLC17b mRNA was also increased but only by about 5% from
30% to 35% (Figs. 5B & D). An increase in the detrusor MLC17b
isoform was similarly reported in response to rabbit PBOO.
However, the relative expression of MLC17b in the normal rabbit
detrusor was only ,8% but then increased more than 7-fold to
,37% in response to PBOO, a value similar to that of the rat
PBOO detrusor [22]. In mammalian SM tissues, the relative
expression of the MLC17b isoform has been found to exhibit an
inverse relationship with the Vmax of the particular SM tissue [50]
and MLC17 isoform exchange/reconstitution demonstrated that
the relative MLC17b expression related to a lower ATPase activity
and Vmax [9,51,52] thus correlating with our current finding in
the rat PBOO model. Again, the SM1 mRNA was increased by
only about 5% compared to SM2 mRNA from 70% to 75%
(Figs. 5C & D). This is similar to what has been reported in the
rabbit and mouse in response to PBOO but the changes in these
species were much greater with the rabbit SM1 increased from
,35% to ,50% [24,26] and mouse SM1 increased from 47% to
80% [25]. Of note, the 70% relative expression of SM1 is much
higher in the normal rat bladder than either the rabbit or mouse.
It has been reported that the tail of the SM1 isoform may inhibit
contraction [53,54] which would support a role for the increased
SM1 expression correlating with our decreased force generated by
detrusor from PBOO rats. However, selective knock out of the
SM2 isoform (thus all SM1 type MHC remaining) in mice has
been shown to increase KCl and carbachol-induced contraction
[48] and transgene overexpression of SM1 in mice increased
Figure 8. Representative tracings of BLEB-induced inhibitory effects on EFS induced detrusor SM contractions. Upper portion is the
sham group while the lower portion is the PBOO group. The x-axis represents time (min) while the y-axis represents force (mg).
doi:10.1371/journal.pone.0025958.g008
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pression of SM2 decreased bladder contraction by 80% [55].
Thus, based upon these two latter SM1/SM2 MHC genetic
manipulation experiments, the increased expression of SM1 in the
current study would actually be expected to increase force rather
than to decrease.
Since it has been suggested that BLEB efficacy may be impacted
by the relative expression of the SM-A/SM-B SMMHC isoform
composition, we compared the efficacy of BLEB at inhibiting
bladder SM from sham rats to that from PBOO animals which we
demonstrated to have an altered SMM isoform composition
including a 3-fold increase in the relative expression of the SM-A
isoform. Our data revealed that the myosin Type II selective
inhibitor BLEB potently relaxed carbachol pre-contracted detru-
sor SM force maintenance and preincubation with BLEB
attenuated carbachol and EFS induced detrusor contraction, with
sensitivity only slightly attenuated for detrusor from rats with
PBOO but with BLEB still able to provoke complete relaxation of
the PBOO bladder strips. It has been reported that the PBOO/
BPH bladder has enhanced permeability resulting from distension
or inflammation [56]. Thus, it is unlikely the urothelium of PBOO
rats may blunt the BLEB effect.
Finally, to further explore the fact that detrusor strips from
PBOO rats was slightly less responsiveness to BLEB, the
expression of SMMHC II and NMMHC II were examined with
Real-Time RT-PCR. Our data revealed that SMMHC transcript
expression decreased by 30% while NMMHC transcript expres-
sion increased by ,4.5-fold (Fig. 10). As BLEB has been found not
to compete with ATP binding or inhibit myosin light chain kinase
[10] or alter SMM regulatory light chain phosphorylation
levels[14], it thus appears that BLEB functions via binding to
the myosin-ADP-Pi complex and blocking the myosin II in an
actin-detached state. Therefore, the 30% downregulation of
SMMHC and/or the more than 5-fold increase in the relative
ratio of NMMHC II to SMMHC II possibly contributed to the
,20% decreased effect of BLEB for SM from PBOO rats.
However, BLEB was found still effective for PBOO strips. As
shown in Figs. 6 & 9,15 mM( 6)BLEB (equal to 7.5 mM active
BLEB) totally and equally relaxed bladder preparations for both
groups. Moreover, BLEB can directly relax prostatic SM in vitro
Figure 9. Summary graphs of BLEB relaxation and inhibitory effects on rat detrusor strip contractility. Upper left, upper right and lower
panels summarize data shown in Fig. 6, 7 & 8, respectively. Response to stimulus was taken as 100%, while the relaxation or inhibitory effect of BLEB
was evaluated as a percentage of this response. Values are expressed as mean 6 SEM. *=p,0.05 vs PBOO; **=p,0.01 vs PBOO. (n =strips obtained
from 25 different animals, one to two strips were used for each animal).
doi:10.1371/journal.pone.0025958.g009
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45% of patients with OAB [20] which remains in 20–30% patients
even after surgery [57], it is important to note that BLEB may be a
potential therapeutic agent for these patients. As BLEB relaxes SM
via a novel targeting of the SM contractile apparatus, it is further
suggested that when intravesically delivered, side effects such as
the bothersome dry mouth related to anticholingeric therapy can
be avoided. However, we have difficulty to keep BLEB in the
PBOO bladder long enough and in vivo experimentation was not
performed in the present study. Therefore, further studies are
required. It is important to find a practical BLEB delivery
approach for the PBOO/OAB model and BLEB dosing should be
carefully determined with attention paid to find a dose which
relieves OAB symptoms without impairing voiding contraction.
Another limitation for the current study is that protein levels of
SMM isoforms were not determined, as SM-A/SM-B antibodies
are not commercially available at present. However, our previous
study in partial outlet obstructed rabbit bladder demonstrated that
mRNA level correlated well with protein expression [22].
In conclusion, bladder outflow obstruction altered detrusor
SMM isoform composition, expression and functional activities.
PBOO bladder SM contractility was attenuated and switched
from a phasic-type SM to a more tonic phenotype with
overexpression of SM-A, MLC17b, SM1 and NMM. Our novel
data also showed that the myosin II selective inhibitor BLEB
potently inhibited bladder SM contraction but its efficacy
decreased slightly with obstruction but only at lower doses.
Importantly, it seemed that the SMMHC played a more
important role than NMMHC in modulating BLEB inhibitory
ability. The present study provides valuable evidence that BLEB
may be a potential therapeutic agent for the regulation of
myogenic and nerve-evoked DO in OAB.
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